Rugulosin, 8,8'-Dihydroxy-, (1S,1'S,2R,2'R,3S,3'S,9aR,9'aR)- Chemische Eigenschaften,Einsatz,Produktion Methoden

Sicherheitsprofil

Poison by ingestion, intraperitoneal, subcutaneous, and intravenous routes. Questionable carcinogen with experimental carcinogenic and tumorigenic data. Human mutation data reported. When heated to decomposition it emits acrid smoke and irritating fumes.

Rugulosin, 8,8'-Dihydroxy-, (1S,1'S,2R,2'R,3S,3'S,9aR,9'aR)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Rugulosin, 8,8'-Dihydroxy-, (1S,1'S,2R,2'R,3S,3'S,9aR,9'aR)- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
ATK CHEMICAL COMPANY LIMITED	+undefined-21-51877795	ivan@atkchemical.com	China	32957	60
TargetMol Chemicals Inc.		support@targetmol.com	United States	38631	58
Shanghai SuperLan Chemcial Technique Centre	021-2022843681 15618226720	lucy@atkchemical.com	China	9952	58
Shaanxi Dideu Newmaterial Co., Ltd.	029-87576359 15353716720	1039@dideu.com	China	10009	58
Nantong QuanYi Biotechnology Co., Ltd	0513-66337626 18051384581	sales@chemhifuture.com	China	4988	58

---

• Rugulosin, 8,8'-dihydroxy-, (1S,1'S,2R,2'R,3S,3'S,9aR,9'aR)-
• luteoskyrin
• LUTHEOSKIRINE
• (1S,1'S,2R,2'R,3S,3'S,9aR,9'aR)-8,8'-Dihydroxyrugulosin
• [1S,1'S,2R,2'R,3S,3'S,9aR,9'aR,(-)]-8,8'-Dihydroxyrugulosin
• Flavomycelin
• 5H,6H-6,13a,5a,14-[1,2,3,4]Butanetetraylcycloocta[1,2-b:5,6-b']dinaphthalene-5,8,13,16(14H)-tetrone, 1,4,7,9,12,15,17,20-octahydroxy-3,11-dimethyl-, (5aR,6S,13aR,14S,17R,18S,19S,20R)-
• 21884-44-6